At a Glance - Vitiligo vs tinea versicolor

Contributed by Dr Jean Watkins, a retired GP in Hampshire.

Vitiligo

Presentation

  • Altered pigmentation due to destruction of melanocytes.
  • May affect any part of the body, including hair. Most commonly the hands, feet, forearms and face.
  • Presents with well-demarcated white or pale round or oval patches, which may be localised or generalised. Skin itself appears normal.
  • More obvious in dark-skinned patients or after a holiday when areas of skin fail to tan.
  • May follow trauma such as sunburn or emotional stress.
  • Often associated with auto-immune problems such as thyroid disease, pernicious anaemia or alopecia areata.
  • Usually presents before the age of 30, commonly with a family history.
  • Wood's light highlights depigmented areas.

Management

  • Sunscreen to protect depigmented areas that burn rather than tan.
  • Topical steroids. Calcineurin inhibitor on the face may help and cause less damage.
  • Phototherapy - narrow band UVL or PUVA; or laser therapy.
  • If repigmentation fails, depigmentation of normal skin with 20% monobenzylether of hydroquinone may make the vitiligo less obvious.
  • Skin grafts occasionally used for small, persistent unchanging areas.

Tinea versicolor
Tinea versicolor is commonly seen on the trunk, back, arms and legs
Presentation

  • Fungal infection of the skin caused by Malassezia furfur.
  • Most common in teenagers and young adults.
  • Presents with well demarcated, round or oval, white or reddish brown macules with a fine scale.
  • Often first noticed when affected areas fail to tan.
  • Most common on trunk, back, abdomen, upper arms and legs.
  • Recurrences are common.
  • Can confirm diagnosis with skin scraping for microscopy.
  • Affected areas may fluoresce yellow-green under Wood's light.

Management

  • Topical selenium sulphide; topical imidazole antifungal agent such as ketoconazole shampoo, clotrimazole or miconazole.
  • If persistent or widespread, systemic triazole antifungal agent such as fluconazole.
  • Commonly recurs, especially in the immunocompromised.
  • Prophylactic treatment with ketoconazole or fluconazole for one to three days each month may prevent recurrences.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

Doctors who rejoined the NHS workforce in the pandemic must be urged to stay to help...

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GP practices are unlikely to receive stocks of COVID-19 vaccine 'for at least another...

JCVI confirms priority groups for COVID-19 vaccination

JCVI confirms priority groups for COVID-19 vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has published a final...

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

The MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and...